Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Non Operating Interest Expenses (2012 - 2026)

Updated

Phibro Animal Health (PAHC) recorded Non Operating Interest Expenses of $12.25 million in fiscal Q1 2027 (quarter ended Sep 30, 2026), down 2.3% from $12.54 million a year earlier but up 14.4% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Non Operating Interest Expenses (2012 - 2026) Analysis & Trends

On a TTM basis, Phibro Animal Health's Non Operating Interest Expenses came in at $46.12 million as of Sep 30, 2026, up 12.5% year-over-year; for FY2026 (ended Jun 30, 2026), it came in at $46.42 million, up 24.7% from FY2025.

  • Annual Non Operating Interest Expenses has increased for four straight fiscal years, with a four-year compound annual growth rate of 38.3% (FY2022 to FY2026).
  • Across earlier fiscal years, Non Operating Interest Expenses came in at $37.22 million in FY2025 (+61.8%), $23.01 million in FY2024 (+23.2%), $18.68 million in FY2023 (+47.2%) and $12.69 million in FY2022.
  • Quarterly Non Operating Interest Expenses has ranged from $5.65 million in fiscal Q1 2024 to $12.54 million in fiscal Q1 2026 over the past five years.
  • On a year-over-year basis, Non Operating Interest Expenses rose in seven of the last eight quarters, with growth averaging 36.3%.
  • Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 71.0% in fiscal Q3 2025, against a decline of 2.3% in fiscal Q1 2027 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $10.71 million (Q4 2026), $10.68 million (Q3 2026) and $12.48 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 217.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -477.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 269.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn 12.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 12.25 Mn
Jun 30, 2026 10.71 Mn
Mar 31, 2026 10.68 Mn
Dec 31, 2025 12.48 Mn
Sep 30, 2025 12.54 Mn
Jun 30, 2025 9.03 Mn
Mar 31, 2025 9.65 Mn
Dec 31, 2024 9.78 Mn
Sep 30, 2024 8.77 Mn
Jun 30, 2024 6.00 Mn
Mar 31, 2024 5.65 Mn
Dec 31, 2023 5.72 Mn
Sep 30, 2023 5.65 Mn
Jun 30, 2015 3.79 Mn
Mar 31, 2015 3.66 Mn
Dec 31, 2014 3.55 Mn
Sep 30, 2014 3.55 Mn
Jun 30, 2014 6.53 Mn
Mar 31, 2014 7.81 Mn
Dec 31, 2013 7.78 Mn
API Access

Phibro Animal Health Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=PAHC&period=max&api_key=YOUR_API_KEY